• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Douglas Davenport

Information Technology Leaders to Convene at the 2024 AI Training Summit for Financial Investigators

Mad Hedge AI

WASHINGTON, April 24, 2024 – In a world where financial crimes are becoming increasingly sophisticated, information technology (IT) leaders and AI experts will gather in Washington DC next month for the 2024 AI Training Summit for Financial Investigators. This timely event, to be held at the National Press Club on May 15th and 16th, aims to empower investigators with the latest artificial intelligence (AI) tools and techniques to combat complex financial fraud, money laundering, and other illicit activities.

The Growing Impact of AI on Financial Investigations

Artificial intelligence is rapidly transforming the field of financial investigations. AI-powered algorithms can analyze vast datasets, uncover hidden patterns, and detect anomalies that would be difficult, if not impossible, for humans to identify. This enhanced ability to process information is revolutionizing how investigators approach cases, leading to faster and more accurate identification of fraudulent activities.

Summit Highlights

The 2024 AI Training Summit will bring together thought leaders from government, industry, and academia to share cutting-edge knowledge and strategies for leveraging AI in financial investigations. Key topics include:

  • Harnessing Big Data for Fraud Detection: Experts will discuss techniques for using AI to analyze large volumes of financial data to identify suspicious transactions, red flags, and high-risk entities.
  • AI-Driven Pattern Recognition: Deep dives into machine learning algorithms and how they can uncover hidden patterns and connections that might indicate fraudulent behavior.
  • Visualizing Financial Data: Innovative approaches to using data visualization with AI, turning complex financial information into easily understandable patterns, aiding investigators.
  • Anti-Money Laundering (AML) Solutions: Exploring AI solutions tailored to detecting and preventing money laundering activities.
  • Cybersecurity and AI: Addressing the intersection of cybersecurity and AI in financial investigations, with a focus on protecting sensitive data and mitigating cyber threats.
  • Ethical Considerations: Discussions around the ethical implications of AI in investigations, ensuring transparency, fairness, and accountability in algorithmic decision-making.

Keynote Speakers and Panelists

The summit will feature keynote presentations and panel discussions from leading experts, including:

  • Patricia Delafuente, Data Scientist, NVIDIA: Ms. Delafuente will provide insights into the latest advancements in AI for complex financial data analysis, including the use of GPUs (graphical processing units) to accelerate machine learning workloads.
  • Sanjeev Pulapaka, Director of Technology Solutions, Amazon Web Services (AWS): Mr. Pulapaka will highlight the potential of cloud-based AI solutions for scaling financial investigations while maintaining the highest security standards.
  • Members of Federal Government Investigative Units: Officials from agencies such as the FBI, FinCEN (Financial Crimes Enforcement Network), and the SEC (Securities and Exchange Commission) will share real-world case studies and best practices for AI-powered financial investigations.

Transforming the Investigator’s Toolkit

The AI Training Summit for Financial Investigators isn't just about exploring theory. It's designed to provide practical guidance and actionable takeaways. Attendees will participate in hands-on workshops, learning how to:

  • Build AI models: Understanding the core principles of training AI models for specific financial investigation tasks.
  • Evaluate AI solutions: Exploring criteria for assessing the effectiveness and suitability of different AI tools for financial investigations.
  • Implement AI responsibly: Developing strategies for integrating AI into existing investigative workflows while addressing ethical and security considerations.

Visit https://aisummit.link/ to learn more about the upcoming event in May.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2024/04/Screenshot-2024-04-24-163344.jpg 616 925 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2024-04-24 16:42:312024-04-24 16:45:48Information Technology Leaders to Convene at the 2024 AI Training Summit for Financial Investigators
april@madhedgefundtrader.com

April 24, 2024

Tech Letter

Mad Hedge Technology Letter
April 24, 2024
Fiat Lux

 

Featured Trade:

(RUNNING ON FUMES)
(ARKK), (NVDA), (ROKU), (TSLA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-24 14:04:102024-04-24 15:47:19April 24, 2024
april@madhedgefundtrader.com

Running On Fumes

Tech Letter

This is a story of how important it is to accurately time the tech business cycle and to unload winners when they run dry.

I am talking about Cathy Wood’s ARKK (ARKK) fund and how it has suddenly gone south with no savior in sight.

The beginning of every tech innovation cycle is usually the best time to invest in “innovation” partly because this point in time also coincides with low interest rates.

Rates were historically low for a long time and ARKK did well.

Many of these tailwinds have now gone in complete reverse and Wood’s biggest position Tesla (TSLA) is feeling the brunt of it.

Tesla issued a poor earnings report yesterday, but CEO Elon Musk turned around the price action by chronicling how Tesla is about to roll out cheaper cars.

Cheaper EVs play into the hands of the Chinese who can do it a lot cheaper for better quality.

Fighting the Chinese at its own game is a fool’s errand.

I believe the 12% pop today is largely due to algorithmic buying and when traders see through this empty strategy, it will usher in the next down leg for Tesla and one of its largest positions.

One of ARKK’s other large positions is in ROKU (ROKU) which navigates the streaming sub-sector.

Streaming, aside from Netflix (NFLX), has gone nowhere lately as prices for consumers have skyrocketed but services haven’t improved.

Growth has saturated is the end result.

It’s gone from bad to worse.

It’s a far cry when investors rushed into her funds and it won big during the pandemic when the star fund manager became a social-media sensation by making bold bets on disruptive technology stocks such as Tesla, Zoom Video Communications, and Roku.

Investors have pulled a net $2.2 billion from ARK Investment Management this year, a withdrawal that dwarfs the outflows in all of 2023. Total assets in those funds have dropped 30% in less than four months to $11.1 billion—after peaking at $59 billion in early 2021, when ARK was the world’s largest active ETF manager. 

Loyal shareholders have become disillusioned and this should be a better year for the ARK style of investing in growth and disruptive technology, but they are concentrated in companies that have underperformed.

By the end of last year, ARK funds had destroyed more wealth than any other asset manager over the previous decade, losing investors a collective $14.3 billion.

Nvidia’s absence in ARK’s flagship fund has been a particular pain point. The innovation fund sold off its position in January 2023, just before the stock’s monster run began. The graphics chip maker’s shares have roughly quadrupled since.

Wood, a longtime proponent of cryptocurrency, has done better standing by her bet on crypto exchange Coinbase Global, whose shares have quadrupled over the past year. The stock is still down 47% from its peak in 2021.

The ARKK ETF has lost 75% of its value since 2021 which has infuriated investors who thought they could chase innovation to sky-high valuations.

The ETF languishing in the doldrums represents Wood’s inability to innovate her trading philosophy and grapple with the reality that we are in a very late cycle in tech and blowing one’s wad on some pie-in-the-sky dream isn’t going to cut it in 2024.

Still with the robust business models that can weather high interest rates and high inflation.

 

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-24 14:02:572024-04-24 15:47:03Running On Fumes
Mad Hedge Fund Trader

April 24, 2024 - Quote of the Day

Tech Letter

“If you're trying to create a company, it's like baking a cake. You have to have all the ingredients in the right proportion.” – Said CEO of Tesla Elon Musk

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/12/elon-musk-e1696019090338.png 372 380 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-04-24 14:00:552024-04-24 15:46:43April 24, 2024 - Quote of the Day
april@madhedgefundtrader.com

April 24, 2024

Jacque's Post

 

(WALL STREET IS PAYING ATTENTION TO THE METALS SECTOR)

April 24, 2024

 

Hello everyone,

 

Arizona Metals Corp.

I’m diving into a Canadian gold explorer today that is only priced at $2.21.

New drilling results from its Kay Mine Project, located 45 miles north of Phoenix, Arizona, suggest the presence of high-grade copper and gold mineralization within the drilled areas, which could potentially lead to the discovery of a significant mineral resource.

Analysts at Scotiabank believe the company has completed 106,000 meters of drilling on the Kay property and remains well-funded, with $31 million in cash at the end of last year to complete the remaining 53,000 meters of the drill program.

There is an expectation by analysts at Scotiabank that shares will rise 114% to $4.50 Canadian dollars ($3.27) from current levels.

The Kay Mine, a wholly owned gold-copper-zinc exploration-stage project, is Arizona Metal’s flagship mine.  According to the company, minerals have been identified through drilling from 150 metres to at least 900 meters below the surface.

Arizona Metal’s stock has a consensus price target of six Canadian dollars, representing a potential upside of 185%, according to FactSet data.

BMO Capital Markets analyst Rene Cartier has a price target of 6.50 Canadian dollars on the stock, giving it an upside potential of 209%.

Beacon Securities analyst Bereket Berhe, meanwhile, has set a price target of 10.50 Canadian dollars, suggesting a potential upside of 400%.  This makes Scotiabank’s price target the most conservative among analysts polled by FactSet.

Investments in mineral exploration companies are often considered to be high-risk, so if you are risk-averse, please skip this investment.

 

 

Wall Street is bullish on copper.

Supply risks and rising demand amid the energy transition and the artificial intelligence boom have Wall Street taking note and becoming increasingly bullish on this metal.

Copper is used in data centres for power cables, electrical connectors, power strips, and more.

Global copper demand by data centres will increase from 239 kt (thousand tons) in 2023 to at least 450 kt per annum in 2030.

Jefferies analysts argue that the potential demand growth will exacerbate an underlying copper market deficit, ultimately leading to higher prices.

Data centres house vast amounts of computing power needed for AI workloads, and that need is set to grow as many tech companies are rapidly developing infrastructure for artificial intelligence.  Large language models require a lot of data centre capacity.

Recently, Morgan Stanley predicted that the price of the metal will reach $10,500 per ton by the fourth quarter of this year – representing around 12% upside.

Copper is also widely considered an indicator of economic health.  The metal has a wide range of applications throughout construction and industry.  It’s also a critical component in electric vehicles, used in batteries, wiring, charging points, and more.

If you want another copper stock besides Freeport McMoRan (FCX) for your investment portfolio, you could consider Solaris Resources (SLSR) Price of $3.33.  Analysts have given it a 100% buy rating, with the potential for more than 100% upside.

If you want to consider ETFs you could have a look at Sprott Copper Miners ETF (COPP) and the iShares Copper and Metals Mining ETF (ICOP), as well as the Global X Copper Miners ETF  (COPX).

 

 

 

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-24 12:00:442024-04-24 11:30:12April 24, 2024
april@madhedgefundtrader.com

April 24, 2024

Diary, Newsletter, Summary

Global Market Comments
April 24, 2024
Fiat Lux

 

Featured Trade:

(THEY’RE NOT MAKING AMERICANS ANYMORE)
(SPY), (EWJ), (EWL), (EWU), (EWG), (EWY), (FXI), (EIRL), (GREK), (EWP), (IDX), (EPOL), (TUR), (EWZ), (PIN), (EIS)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-24 09:04:432024-04-24 10:13:13April 24, 2024
april@madhedgefundtrader.com

They’re Not Making Americans Anymore

Diary, Newsletter

If demographics is destiny, then America’s future looks bleak. You see, they’re not making Americans anymore.

At least that is the sobering conclusion of the latest Economist magazine survey of the global demographic picture.

I have long been a fan of demographic investing, which creates opportunities for traders to execute on what I call “intergenerational arbitrage”.  When the numbers of the middle-aged big spenders are falling, risk markets plunge. Front run this data by two decades, and you have a great predictor of stock market tops and bottoms that outperforms most investment industry strategists.

You can distill this even further by calculating the percentage of the population that is in the 45-49 age bracket.

The reasons for this are quite simple. The last five years of child rearing are the most expensive. Think of all that pricey sports equipment, tutoring, braces, SAT coaching, first cars, first car wrecks, and the higher insurance rates that go with it.

Older kids need more running room, which demands larger houses with more amenities. No wonder it seems that dad is writing a check or whipping out a credit card every five seconds. I know, because I have five kids of my own. As long as dad is in spending mode, stock and real estate prices rise handsomely, as do most other asset classes. Dad, you’re basically one generous ATM.

As soon as kids flee the nest, this spending grinds to a juddering halt. Adults entering their fifties cut back spending dramatically and become prolific savers. Empty nesters also start downsizing their housing requirements, unwilling to pay for those empty bedrooms, which in effect, become expensive storage facilities.

This is highly deflationary and causes a substantial slowdown in GDP growth.  That is why the stock and real estate markets began their slide in 2007, while it was off to the races for the Treasury bond market.

The data for the US is not looking so hot right now. Americans aged 45-49 peaked in 2009 at 23% of the population. According to US census data, this group then began a 13-year decline to only 19% by 2022.

You can take this strategy and apply it globally with terrific results. Not only do these spending patterns apply globally, they also back-test with a high degree of accuracy. Simply determine when the 45-49 age bracket is peaking for every country and you can develop a highly reliable timetable for when and where to invest.

Instead of pouring through gigabytes of government census data to cherry-pick investment opportunities, my friends at HSBC Global Research, strategists Daniel Grosvenor and Gary Evans, have already done the work for you. They have developed a table ranking investable countries based on when the 34-54 age group peaks—a far larger set of parameters that captures generational changes.

The numbers explain a lot of what is going on in the world today. I have reproduced it below. From it, I have drawn the following conclusions:

* The US (SPY) peaked in 2001 when our first “lost decade” began.

*Japan (EWJ) peaked in 1990, heralding 32 years of falling asset prices, giving you a nice backtest.

*Much of developed Europe, including Switzerland (EWL), the UK (EWU), and Germany (EWG), followed in the late 2000s and the current sovereign debt debacle started shortly thereafter.

*South Korea (EWY), an important G-20 “emerged” market with the world’s lowest birth rate peaked in 2010.

*China (FXI) topped in 2011, explaining why we have seen three years of dreadful stock market performance despite torrid economic growth. It has been our consumers driving their GDP, not theirs.

*The “PIIGS” countries of Portugal, Ireland (EIRL), Greece (GREK), and Spain (EWP) don’t peak until the end of this decade. That means you could see some ballistic stock market performances if the debt debacle is dealt with in the near future.

*The outlook for other emerging markets, like Indonesia (IDX), Poland (EPOL), Turkey (TUR), Brazil (EWZ), and India (PIN) is quite good, with spending by the middle age not peaking for 15-33 years.

*Which country will have the biggest demographic push for the next 38 years? Israel (EIS), which will not see consumer spending max out until 2050. Better start stocking up on things Israelis buy.

Like all models, this one is not perfect, as its predictions can get derailed by a number of extraneous factors. Rapidly lengthening life spans could redefine “middle age”. Personally, I’m hoping 72 is the new 42.

Emigration could starve some countries of young workers (like Japan) while adding them to others (like Australia). Foreign capital flows in a globalized world can accelerate or slow down demographic trends. The new “RISK ON/RISK OFF” cycle can also have a clouding effect.

So why am I so bullish now? Because demographics is just one tool in the cabinet. Dozens of other economic, social, and political factors drive the financial markets.

What is the most important demographic conclusion right now? That the US demographic headwind veered to a tailwind in 2022, setting the stage for the return of the “Roaring Twenties.” With the (SPY) up 27% since October, it appears the markets heartily agree.

While the growth rate of the American population is dramatically shrinking, the rate of migration is accelerating, with huge economic consequences. The 80-year-old trend of population moving from North to South to save on energy bills picking up speed, the Midwest is getting hollowed out at an astounding rate as its people flee to the coasts, all three of them.

As a result, California, Texas, Florida, Washington, and Oregon are gaining population, while Missouri, Iowa, Nebraska, Kansas, and Wyoming are losing it (see map below). During my lifetime, the population of California has rocketed from 10 million to 40 million. People come in poor and leave as billionaires, as Elon Musk did.

In the meantime, I’m going to be checking out the shares of the matzo manufacturer down the street.

 

 

 

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/04/manischewitz.png 370 364 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-24 09:02:502024-04-24 10:12:59They’re Not Making Americans Anymore
april@madhedgefundtrader.com

Trade Alert - (AMZN) April 23, 2024 - STOP LOSS - SELL

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-23 12:11:502024-04-23 12:12:22Trade Alert - (AMZN) April 23, 2024 - STOP LOSS - SELL
april@madhedgefundtrader.com

April 23, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
April 23, 2024
Fiat Lux

 

Featured Trade:

(A DRUG KINGPIN HIDING IN PLAIN SIGHT)

(ABBV)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-23 12:02:122024-04-23 11:18:10April 23, 2024
april@madhedgefundtrader.com

A Drug Kingpin Hiding In Plain Sight

Biotech Letter

Have you ever thought about big pharma stocks as potential goldmines? I mean, we usually don’t gossip about the likes of AbbVie (ABBV) over lunch, but maybe we should.

After all, those unassuming pharma giants could be hiding some serious potential for your portfolio. Let's dive into whether investing in AbbVie might just be your ticket to millionaire status.

Admittedly, AbbVie isn’t your typical headline grabber unless it’s about their next big thing in medicine. They’ve got a real knack for plucking the right strings in R&D, which not only keeps them competitive but also paves the way for massive returns.

Case in point: Humira. This blockbuster drug treats everything from arthritis to psoriasis and even though it’s facing generic competition left and right, it still bagged $14.4 billion in sales in 2023. That's no small potatoes, considering it’s a chunk of AbbVie's hefty $54.3 billion revenue.

So how does AbbVie keep the Humira money train rolling? They play smart with pricing and patents, and they've got a backup band ready with new drugs like Skyrizi and Rinvoq. These two are set to take over the stage with projected sales hitting a sweet tune of $27 billion by 2027.

And let me tell you, the transition from Humira to these newcomers is like swapping an old favorite band’s vinyl for their latest digital remix — just as good, if not better.

But here’s the deal. AbbVie isn’t just remixing their old hits. They’re producing whole new albums. With every new drug approval, they’re not simply aiming to keep up — they’re looking to lead the charts. And with their pipeline promising a few more blockbusters, it looks like AbbVie could keep the record-topping releases coming.

Take their recent shopping spree for example: snapping up Cerevel for a cool $8.7 billion. This isn’t some random acquisition. It’s a strategic move that bolsters AbbVie's impressive neurology treatment portfolio.

Cerevel is close to getting approval for a new schizophrenia drug, a game-changer that could redefine how we treat this debilitating disorder. Traditional medications often have harsh side effects, but Cerevel's new class of drugs shows promise in minimizing those risks. Think of it as a gentler approach that still packs a punch.

And there's serious money in this space. The neurological market is huge – around $3.82 billion – and growing fast.

Once Cerevel gets its FDA nod, I'm projecting revenues of around $200 million by 2025, and that's just scratching the surface. They could grab a hefty 2% market share by 2028.

But their ambition doesn't stop there. AbbVie wasn't content with just rocking the neurology charts. They also went and snagged ImmunoGen earlier this year for a whopping $10.1 billion, marking their entry into the lucrative battle against solid tumors.

ImmunoGen has this cutting-edge technology called antibody-drug conjugates (ADCs) – it's like guided missiles that pinpoint cancer cells while leaving healthy ones unharmed.

Their drug, Elahere, already got the green light last year for ovarian cancer and raked in a cool $246 million in just nine months. And that's just the start.

The ovarian cancer market is a beast, valued at $4.35 billion and growing rapidly. I predict Elahere's sales could skyrocket to $1.6 billion by 2028.

Now, let’s talk dividends because who doesn’t like a good payout?

AbbVie’s rocking a forward-dividend yield of 3.4%, and they've been increasing their dividends for decades. It’s like getting a steady rhythm of cash that just keeps getting louder.

And don’t forget about the share buybacks. AbbVie bought back nearly $2 billion of its own stock in 2023. That’s a lot of faith in their future hits and a sign that they’re betting big on their own success.

So, sure, AbbVie isn’t going to make you a millionaire overnight — it’s not a lottery ticket. But if you’re in the game for the long haul, this stock could be a key player in your wealth-building lineup.

With a solid track record, a pipeline full of potential, and a strategy that’s clearly focused on growth, AbbVie is looking like a pretty smart pick. I suggest you buy the dip.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-04-23 12:00:132024-04-23 11:17:53A Drug Kingpin Hiding In Plain Sight
Page 4 of 16«‹23456›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top